<SEC-DOCUMENT>0001213900-19-013447.txt : 20190905
<SEC-HEADER>0001213900-19-013447.hdr.sgml : 20190905
<ACCEPTANCE-DATETIME>20190724113013
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001213900-19-013447
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20190724

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			American BriVision (Holding) Corp
		CENTRAL INDEX KEY:			0001173313
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				260014658
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		44370 OLD WARM SPRINGS BLVD.
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		845-551-8728

	MAIL ADDRESS:	
		STREET 1:		44370 OLD WARM SPRINGS BLVD.
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	METU BRANDS, INC.
		DATE OF NAME CHANGE:	20150908

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ECOLOGY COATINGS, INC.
		DATE OF NAME CHANGE:	20080821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ecology Coatings, Inc.
		DATE OF NAME CHANGE:	20070711
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<IMG SRC="img_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
24, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Division
of Corporate Finance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
F Street, NE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
D.C. 20549</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Ms. Erin Jaskot and Mr. Jeffrey Gabor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:
American Brivision (Holding) Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment
No.2 to Registration Statement on Form S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Submitted
on June 28, 2019</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
No. 333-228387</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Ms. Erin Jaskot and Mr. Jeffrey Gabor:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
find below our responses to the questions raised by the staff (the &ldquo;<B>Staff</B>&rdquo;) of the Securities and Exchange
Commission (the &ldquo;<B>Commission</B>&rdquo;) in its letter of comments dated July 15, 2019 (the &ldquo;<B>Comment Letter&rdquo;)
</B>relating to Amendment No.2 to the registration statement on Form S-1 (the &ldquo;<B>Amendment No. 2</B>&rdquo;), which was
submitted to the Commission by American BriVision (Holding) Corporation (the &ldquo;<B>Company</B>&rdquo;) on June 28, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s responses are numbered to correspond to the Staff&rsquo;s comments. For your convenience, each of the Staff&rsquo;s
comments contained in the Comment Letter has been restated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also updated the Registration Statement on Form S-1/Amendment No. 3 (&ldquo;<B>Amendment No. 3</B>&rdquo;) which is submitted
to the Commission simultaneously together with this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cover
Page</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Comment
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
We note that you have granted the underwriter an over-subscription option. The use of an over-subscription option, however, is
not appropriate in an offering being conducted on a best efforts, minimum-maximum basis. Please revise accordingly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Response:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has deleted the references to the over-subscription option and increased maximum amount in the registration statement.
Please see Amendment No. 3. &nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recent
Developments, page 2</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Comment:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
We note your disclosure here and on page 77 that the PDC-1421 treatments were found to be safe. Determinations of safety are solely
within the authority of the FDA. Please remove these statement from your disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1185 Avenue of the Americas | 37<SUP>th</SUP>
Floor | New York, NY | 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">T (212) 930 9700 | F (212) 930 9725 | WWW.SRF.LAW</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="img_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Response:&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has removed the statements regarding the safety of PDC-1421 treatments on pages 3 and 77 in Amendment No. 3. Please see
Amendment No. 3.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
you have any questions regarding the foregoing, please do not hesitate to contact the Company&rsquo;s counsel, Jay Kaplowitz,
Esq., David Manno, Esq. and Huan Lou, Esq. of Sichenzia Ross Ference LLP at (212) 930-9700.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Jay Kaplowitz</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay
Kaplowitz</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    behalf of American BriVision (Holding) Corporation</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1185 Avenue of the Americas | 37<SUP>th</SUP>
Floor | New York, NY | 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">T (212) 930 9700 | F (212) 930 9725 | WWW.SRF.LAW</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !^ (D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W'5Y)XM%O
MI+7/VA;>1HB!D[@IQ^N*^4#>7<Q,DMS,\C<NS2$DGOGFOKRO(?&/P?DNKR;4
M/#LD2&4EWLI?E7=WV'M]#79@ZT(-J74RJ1;V/'S+*>LK_P#?1I/-D_YZ/_WU
M5S5-&U+1)_)U2QGM'Z R+\K?1NAJC7JIIJZ,!QEDP?WC_P#?5>\?#)B9),DG
M_1H^IKP0]#7O7PQ_UDG_ %[1UEB?X,CGJ?QZ?J_R/2:*ANF*6<S*<,(V(/H<
M5X^OB36V0$ZI<]/[U>&>H>S45XS_ ,)#K/\ T%+K_OX:?'XGUR,@KJ<Y/^T0
MW\Q0!["Z+(C(PRK#!%<POAN[LO$-K>6E]<260<F2"69CMR#TR>1G'%5_"GBZ
M35+@6%^%%R03'(HP'QU!'K78T %)17S#XJU748_%^M(FHW:HM],%59F  W'M
MFMJ%%U6TF1*7*?3^:,U\D_VOJG_03O?^_P"W^-']KZI_T$[W_O\ M_C75]0?
M\Q'M?(^M:*^2O[7U3_H)WO\ W_;_ !J3^U]3_P"@G>_]_P!O\:/J#_F#VOD?
M65%>4:'\;+&<K%K=B]H_0S0?/'^74#\Z]&TO7-+UN#SM,OX+I._EODCZCJ/Q
MKCG1G#XD:*2>Q:N;2WO8&@NH(YHF'*2*&!_ UP&N?!W0-1W2::TFF3'M'\T>
M?]P]/P(KT:BE"I.'PL;BGN?-VO?"_P 3:*'D2U&H6X_Y:6GS''NAY_+->D?#
M(%990P((MD!!'(->D'I7$>$_^1LUO_KHW_H9KL6(E5HS4C@KP4:U.W=_D=C>
M?\>-Q_US;^5>&)_JU^@KW2Y1I+69%&69& 'OBO*5\&:^$ -D.G_/5?\ &N ]
M PZ*WQX+UX_\N:CZRK5B'P%K4K#S/L\*]RTF<?@!0!F>&HY)?$VGB($L)@QQ
M_=')_2O9*P/#WA>VT%6DW&:Z<8:4C&!Z*.PK>) ZT +7RKXL_P"1SUS_ *_Y
MO_0S7U37C6M?![5]3U[4+^+4[-([FY>959&RH9LX-=>$J1A)N3,ZB;6AY'17
MI_\ PI#6O^@M8_\ ?MZ/^%(:U_T%K'_OV]>A]9I?S&/)(\PJ2KNOZ-+X?UNZ
MTJ>5)9;<@,Z# .0#_6J5;)IJY.Q'W-26\\UI.L]M-)!,O22)RK#\14?<T4WJ
M!WVA?%SQ%I6V.],>IP#@^;\L@'^\.OXBO3O#_P 4?#FNE8GN#873?\L;K"@G
MV;H:^<Z0@$8(KFJ82G/R9:J-'V#D%<CTKBO"?_(UZW_UT;_T,UR7P;\4W<US
M/X>NYFEB2+S;4N<E,'#+GTY!%=9X3_Y&O6_^NC?^AFN)4W3C4B^WZF-=\U6D
M_-_D=Q117C%]J-\NHW0%[<@">0 "4\#<:XSO/9Z*\0_M*_\ ^?\ NO\ OZ:Z
M#PMXIGL=0$%_<22VDQ"[I&SY;=CSVH ]*GD:*WDD2,RLJDA%ZL?05YM;>(;_
M %OQ9IXN"8H%N!MMU/"GW]37IH.1FN2U3P[Y/BFPU>T3]V\X^T*/X3V;_&@#
MKJP+CQIX;M;F6WGUFTCFB<HZ,_*L."#6]7RKXM _X3/7.!_Q_P W_H9KHPU%
M59-,B<N5'T1_PGGA7_H.V?\ WW1_PGGA7_H.V7_?=?+^T>@HVCT%=GU"'<S]
MJSI/'M[;:CXXU.[LYDGMY&4I(AR&^09K J/M4E=L5RQ21D]7<;L?)_=R?]\'
M_"DV/_SSD_[X->TZQ\1=6O/%=WX?\&>&H-2GL25N9IR%0$'!QR,8/')YK=\'
MZ_XCU/5)],\2^$1ILL<7FK<Q$-"PR!MSSS]":XGC&E=Q_$V]EYGSSL?_ )YR
M?]\&EV/_ ,\I/^^#_A7T!\/O&K>,9-;%UIUK:KIT_EAD.=PRW)ST^[6%<?%#
M5]=UB>P\!^&(]4BMSMDNYSMC/N.0 /3)Y]*/K<KVY?Q#V7F5/@OX>N!>7FO7
M$3I"(_L]OO7!<DY8CVX KL?"8/\ PE>M\$#>W)'^V:7P=XA\7ZCJ,]AXE\+K
MIHBCWK<Q2YC;G&T<G)_&H_AMXWN/&UKJ=Q<6,-JUI<>2!$Q.X8ZG-<TZTGSM
MK>Q,Z'-*$K_"=U7B%^C_ -I7?[M_]?)_"?[Q]J[;QYXYNO"&J^'[.WLHKA=4
MG:)VD8@H 4&1CK]_]*H^.OB#K'AKQ9IV@Z1HT.H3WT'F(KR%6+;B,#MVKF4)
M,Z#D-C_\\W_[X/\ A2&-R,>7)_WP?\*Z(^-/B?CCX>Q_^!*__%5)XZ^*=YX*
MUG3+.72HYH[BV6>X^<ATYPP7L<4_9R;L@-_P3KSW5N-+N]_GPKF)V4C>GIGU
M%=E6'=>(;<^#Y_$.G%+F$6C7,)S@/A<@'T]*Y/2?'OB+7_AW#X@TCP_%=ZB]
MTT)LTEPH0$@MDD>@_.ERM@>CU\K^+$?_ (3+6\1R?\?\W1#_ 'S7I>I?$;X@
M:182W^H^"+>VM8AEY9+H8'Z_I4]E\3-0NOAIJ7BV?0K>.2WG$<,9)VRKD MG
M'J2/PKIH2E1?-:]_,B<>8\5V2?\ /*3_ +X-&R3_ )Y2?]\&OJ;POJ"Z_P"%
MM,U:6UBBDO+=)F11D*2,X%>:ZG\9X;#QM+I::3;R:1!=K;37N3D<X9AVX.?R
M-=*QC;LH_B1[+S/(]C_\\I/^^#4FQ_\ GG)_WP?\*^N!#"0"(XR#W"BE\B+_
M )Y)_P!\BH^O_P!T/8^9Y;KOPTUZP\3WGB7P1K*65U=DO<6LX^21B<GG!X)Y
MY'TJQX+^(.N7'BZ7P?XMT^*#5D0O'-;GY7P-W(S_ '>011>>!?'%AJ=Y<>&_
M&SQV]W*TSPW\0D\LL<_+P1^0%7?!7PVDT#7+CQ%K>JOJVN3J5\YAA8P>#CN>
M !VP.,5R-KEU=S8\Z\!"X/@WXE"UW>?B79MZYQ)TKNO@6;,_#F+[-L\X7$GV
MC'7=GC/X8Q[5J> ? 4G@V363->I=KJ,WFA1'MVC+<'UZUS]Y\)M4T?69]2\"
M^(FT@7#9DM)%W1#Z=<CT!'%5*4975P/6*^;OAC_PG?V75O\ A$?[+\C[6?/^
MVYSOYQC';%>L>$/"GB?2]7EU7Q'XKEU*62(Q"VC3;"!G.<=C] *D^'?@67P/
M:ZC#+?)=F[G\X%4V[?:H344UN!Y1XX_X33_A)?"?_"8?V;_Q^'[+]BS_ 'H]
MV[/_  ''XUN?%+^T_P#A</A?^Q?(_M/[+_HWG_ZO=O;[WX9KNO'/@67Q?JF@
MWD=\EL-+G:5E9"WF9*' ]/N?K5'QQ\.]1\3^*-/US3=;&FW%E#Y<;"+<P;<3
MD'/O5QJ1TOY@6O"O_"R/[:'_  E']C_V;Y;9^R9W[^W7MUKC?B396^I?&GPI
M8W<0EMKB+RY$/<$O6R? 'Q!Q_P E&N/^_%:VI?#^[U/QEX;\02ZHI?284256
MCYG89RV>V<TDU&5[@><1WEY\-I-?\#ZM(SZ3?6LTFF7+] 2IP/Q/!]&^M=I\
M%;J&Q^%"7-U*L,$,]P\CN<!5#<DUTOCSP1:>.-"^Q2N(+J)O,MKG;DQMW'N#
MW'T]*YA_A3>GX9Q>$8]:6-A>FYDG6,[9%))V%<^I!_"ASC*.NX'.,=1^-WBO
M8IEM?!VG2\G[IG;_ .*/_CH]S78_%BSM]/\ A)?VEI"D-O"D:1QH,!5## %8
MVG?"_P 9:18QV6G>.VM;6/.V**V  SS6S-X!U[4? ^IZ#K'B8W]Q=R*T=S)%
M_JU&.,?A0Y1NK/1 5[7Q$/"WP%T[4P1YRZ;%' #WD8 +^IS^%>5Z=/X/;X1:
MAIE[K,0\07<IO<,CDB5?NJ3C&2,C/J]>J:U\+[O6?#7AG0'U=(['20GG@1',
MY  R.>.-W_?5=<O@KPNJA1X=TO &/^/1/\*%4C'[P,+X2>)?^$C\"6GFONO+
M'_19_7Y?NG\5Q7=UPOA'P!+X0\5:O?65\ATK4#N%D(R/*;.1@].,D?3%=U64
M[<UT!Y%'\6/$E_J^IV.C>#&U!;"Y>!WCN3QAB 2-O&<5IZ#\59+GQ+!X?\2>
M'[G0[^YP(/,?<CD]!T&,XXZBN \&>(]9\/>+/%QTGPU<ZUYVH2>9Y#[?*P[X
MSP>M6K&[U3XJ_%*Q-_;0Z5%H)\R2U9OWW##(]2<@ ]@/K70Z<==- /2?'7Q&
ML_!CV]E%:2:CJ]U_J+.(X.,X!8X.,G@<'-<M<?$OQWH4"ZCX@\$"/2S@N\$A
MWQ _WN3C\<?A5.Q$3?M,WO\ :>/,%M_H8;U\L8Q_P'?7L&IBU.E78OMGV0PO
MYWF?=V8.<^V,UG[L;*UP,3_A.M$;P0_BR.9GTY(BY"K\X;IL(_O9XKAK/XD>
M/]7MAJNE^!DETH\H&E/F2+_L^OX"L?X/Z$OB?X=>(M&OC*NFW-SMB9>JMM!)
M'N"%JY'I7Q.^&^G,NG7-EK>BVH+"%UPZ(.3@=0/8$U7)%-KJ!VE]\18-*^'\
M7BC4]+NK228[$L92!(SG.!GL."<GMVKF8OB'\1&M5U5O 8?2W&]4CD/G;/7O
MV_V:U<:=\:OALI826,IER"/G\F9>/^!*0?;@^M<W/??$WX::<);PV.N:': *
M7SAT3( ST(].^*48QVMJ![#IMXVH:9:WCVTMLT\2R&&7&],C.#CO5NLGPWKM
MMXF\.V.LVBND-U'O"/U4YP1^!!%:U8/1@%%%% !1110 4444 %%%% '$>!_
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&14ZL#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
